Atlas Trials

Ausper Biopharma Co., Ltd.

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ausper Biopharma Co., Ltd.

RecordFirmDate
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function. (NCT07600788)Ausper Biopharma Co., Ltd.2026-07-09
Study of AHB-171 in Chronic Hepatitis B Participants (NCT07630727)Ausper Biopharma Co., Ltd.2026-06-24
A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B (NCT07635186)Ausper Biopharma Co., Ltd.2026-06-05
A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants (NCT07511218)Ausper Biopharma Co., Ltd.2026-04-13
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) (NCT07137910)Ausper Biopharma Co., Ltd.2025-09-04
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection (NCT07146100)Ausper Biopharma Co., Ltd.2025-08-28
Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE) (NCT07246889)Ausper Biopharma Co., Ltd.2025-08-12
A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) (NCT06993480)Ausper Biopharma Co., Ltd.2025-07-15
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs (NCT07069569)Ausper Biopharma Co., Ltd.2025-06-08
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB) (NCT06829329)Ausper Biopharma Co., Ltd.2024-12-13
Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB). (NCT06550128)Ausper Biopharma Co., Ltd.2024-07-10
A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients (NCT06115993)Ausper Biopharma Co., Ltd.2023-08-03

Track Ausper Biopharma Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.